Reversible cerebral vasoconstriction syndrome with associated myocardial injury: A case report
Article Sidebar
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloads
Societal impact
Main Article Content
Abstract
Reversible Cerebral Vasoconstriction Syndrome is a rare condition, and its pathophysiology is not yet fully understood. Its clinical presentation is characterized by neurological manifestations such as “thunderclap” headache, focal deficit, vomiting, photophobia, and, in severe cases, it can lead to complications such as ischemic or hemorrhagic cerebrovascular events. The diagnosis is made through cerebral angiography, CT angiography, or magnetic resonance angiography, which demonstrate vasoconstriction of the cerebral arteries with spontaneous resolution, which in most cases is consistent with a good clinical prognosis. Here, we present the case of a patient with reversible cerebral vasoconstriction syndrome and associated myocardial injury, where a diagnosis was achieved through imaging and timely treatment. The importance of this case lies in raising awareness about the early recognition of a rare myocardial complication of reversible cerebral vasoconstriction syndrome, which carries a risk of morbidity and mortality within the spectrum of cerebrovascular disorders.
Article Details
References
Arrigan MT, Heran MKS, Shewchuk JR. Reversible cerebral vasoconstriction syndrome: An important and common cause of thunderclap and recurrent headaches. Clin Radiol. 2018;73(5):417-27.
Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: Reversible cerebral vasoconstriction syndromes. Ann Intern Med. 2007;146(1):34-44.
Hammad TA, Hajj-Ali RA. Primary angiitis of the central nervous system and reversible cerebral vasoconstriction syndrome. Curr Atheroscler Rep. 2013;15(8):346.
Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D. Reversible cerebral vasoconstriction syndrome, Part 1: Epidemiology, pathogenesis, and clinical course. Am J Neuroradiol. 2015;36(8):1392-9.
Singhal AB, Hajj-Ali RA, Topcuoglu MA, Fok J, Bena J, Yang D, Calabrese LH. Reversible cerebral vasoconstriction syndromes: Analysis of 139 cases. Arch Neurol. 2011;68(8):1005-12.
Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM. Reversible cerebral segmental vasoconstriction. Stroke. 1988;19(9):1159-70.
Burton TM, Bushnell CD. Reversible cerebral vasoconstriction syndrome. Stroke. 2019;50(8):2253-8.
de Boysson H, Parienti JJ, Mawet J, Arquizan C, Boulouis G, Burcin C, et al. Primary angiitis of the CNS and reversible cerebral vasoconstriction syndrome: A comparative study. Neurology. 2018;91(16):e1468-78.
Ducros A, Bousser MG. Reversible cerebral vasoconstriction syndrome. Pract Neurol. 2009;9(5):256-67.
Singhal AB, Bernstein RA. Postpartum angiopathy and other cerebral vasoconstriction syndromes. Neurocrit Care. 2005;3(1):91-7.
Chen SP, Chung YT, Liu TY, Wang YF, Fuh JL, Wang SJ. Oxidative stress and increased formation of vasoconstricting F2-isoprostanes in patients with reversible cerebral vasoconstriction syndrome. Free Radic Biol Med. 2013;61:243-8.
Marra A, Vargas M, Striano P, Del Guercio L, Buonanno P, Servillo G. Posterior reversible encephalopathy syndrome: The endothelial hypotheses. Med Hypotheses. 2014;82(5):619-22.
Chen SP, Fuh JL, Wang SJ, Tsai SJ, Hong CJ, Yang AC. Brain-derived neurotrophic factor gene Val66Met polymorphism modulates reversible cerebral vasoconstriction syndromes. Plos One. 2011;6(3):e18024.
Cappelen-Smith C, Calic Z, Cordato D. Reversible cerebral vasoconstriction syndrome: Recognition and treatment. Curr Treat Options Neurol. 2017;19(6):21.
Spadaro A, Scott KR, Koyfman A, Long B. Reversible cerebral vasoconstriction syndrome: A narrative review for emergency clinicians. Am J Emerg Med. 2021;50:765-72.
Chen SP, Fuh JL, Wang SJ. Reversible cerebral vasoconstriction syndrome: Current and future perspectives. Expert Rev Neurother. 2011;11(9):1265-76.
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al; ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237-69.